Emergent BioSolutions (EBS) Gains from Investment Securities (2020 - 2026)
Emergent BioSolutions (EBS) posted Gains from Investment Securities of -$500000.0 for Q2 2026, up 94.05% on a QoQ basis from -$8.4 million in Q1 2026.
Powered by 
Analysis
Emergent BioSolutions (EBS) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Emergent BioSolutions has reported Gains from Investment Securities for 7 years, with the latest figure at -$500000.0 in Q2 2026.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to -$500000.0 in Q2 2026; TTM through Jun 2026 was -$1.6 million, a 78.08% increase from a year earlier, with the FY2025 full-year figure at $5.5 million, up 400.0% from the prior year.
- Gains from Investment Securities was -$500000.0 for Q2 2026 at Emergent BioSolutions, up from -$8.4 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $7.3 million in Q4 2025, with the low at -$9.5 million in Q1 2025.
- Average Gains from Investment Securities over 5 years is -$366666.7, with a median of $400000.0 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities soared 266.67% in 2024, then tumbled 2000.0% in 2025.
- Over 5 years, Gains from Investment Securities stood at $200000.0 in 2022, then jumped by 200.0% to $600000.0 in 2023, then jumped by 266.67% to $2.2 million in 2024, then jumped by 231.82% to $7.3 million in 2025, then tumbled by 106.85% to -$500000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$500000.0 (Q2 2026), -$8.4 million (Q1 2026), and $7.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -500,000.00 |
| Mar 31, 2026 | -8.40 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Mar 31, 2025 | -9.50 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 600,000.00 |
| Sep 30, 2023 | -1.10 Mn |
| Jun 30, 2023 | 400,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 900,000.00 |
| Jun 30, 2021 | 600,000.00 |
| Mar 31, 2021 | 1.10 Mn |
| Dec 31, 2020 | 400,000.00 |
API Access
Emergent BioSolutions Gains from Investment Securities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-investment-securities", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();